Cannara Biotech (STU:8CB0) Pre-Tax Income : €3.57 Mil (TTM As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cannara Biotech's pretax income for the three months ended in Nov. 2024 was €2.05 Mil. Its pretax income for the trailing twelve months (TTM) ended in Nov. 2024 was €3.57 Mil. Cannara Biotech's pretax margin was 12.10%.

During the past 7 years, Cannara Biotech's highest Pretax Margin was 12.13%. The lowest was -618.60%. And the median was -8.98%.

Cannara Biotech Pre-Tax Income Historical Data

The historical data trend for Cannara Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Pre-Tax Income Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Pre-Tax Income

Get a 7-Day Free Trial

-8.36

-1.03

1.76

4.73

2.98

Cannara Biotech Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Pre-Tax Income	Get a 7-Day Free Trial															1.42	-2.37	1.37	2.52	2.05

Competitive Comparison of Cannara Biotech's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Cannara Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cannara Biotech's Pretax Income for the fiscal year that ended in Aug. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	5.344	+	1.271	+	-2.874	+	0.119	+	-0.882
	=	2.98

Cannara Biotech's Pretax Income for the quarter that ended in Nov. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	2.854	+	-0.009	+	-0.709	+	0.041	+	-0.132
	=	2.05

Pre-Tax Income for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.57 Mil.

Cannara Biotech (STU:8CB0) Pre-Tax Income Explanation

Cannara Biotech's Pretax Margin for the quarter that ended in Nov. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	2.045	/	16.901
	=	12.10%

During the past 7 years, Cannara Biotech's highest Pretax Margin was 12.13%. The lowest was -618.60%. And the median was -8.98%.

Cannara Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (STU:8CB0) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

LOVFF:USA LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Cannara Biotech Headlines

No Headlines